How common is otogenic meningitis? A retrospective study in southern Sweden over 18 years.

Nora Bjar, Ann Hermansson, Marie Gisselsson-Solen
Author Information
  1. Nora Bjar: Vårdcentralen Lunden, Ystadgatan 53c, 214 44, Malmö, Sweden.
  2. Ann Hermansson: Department of Otorhinolaryngology, Head and Neck Surgery, Skåne University Hospital, 221 85, Lund, Sweden.
  3. Marie Gisselsson-Solen: Department of Otorhinolaryngology, Head and Neck Surgery, Skåne University Hospital, 221 85, Lund, Sweden. marie.gisselsson-solen@med.lu.se. ORCID

Abstract

BACKGROUND: Bacterial meningitis is a rare, but life-threatening disease, which sometimes occurs as a complication to acute otitis media (AOM). The proportion of meningitis cases originating from AOM is not clear.
PURPOSE: The aim of this study was to investigate the proportion of meningitis cases caused by AOM, to compare risk factors, bacteriology and outcome between otogenic and non-otogenic meningitis, and to analyse the incidence of bacterial meningitis after the introduction of conjugate pneumococcal vaccines (PCV).
METHODS: The medical charts of all patients admitted to hospitals in southern Sweden with bacterial meningitis between 2000 and 2017 were retrieved. Based on otoscopy and/or imaging, the proportion of otogenic meningitis cases was calculated, as were annual incidences.
RESULTS: A total of 216 patients were identified, 25 of whom died. The proportion of otogenic meningitis was 31% but varied from 6% among teenagers to 40% among adults. Before PCV, 23% of all meningitis cases were children < 2 years, compared to 1% post-PCV. The average incidence in the adult population, on the other hand, increased post-PCV, though there were large annual variations. S. pneumoniae was the most commonly identified pathogen in everyone but teenagers, in whom N. meningitidis was predominant.
CONCLUSION: AOM is an important cause of meningitis in children and adults. Though bacterial meningitis almost disappeared in children < 2 years after the introduction of PCV, the incidence of pneumococcal meningitis in adults seems to have increased.

Keywords

References

  1. Med Mal Infect. 2015 Nov-Dec;45(11-12):446-55 [PMID: 26607227]
  2. Lancet. 2012 Nov 10;380(9854):1703-11 [PMID: 23141619]
  3. Nat Rev Dis Primers. 2016 Sep 08;2:16063 [PMID: 27604644]
  4. Lancet Infect Dis. 2010 May;10(5):317-28 [PMID: 20417414]
  5. JAMA. 2022 Dec 6;328(21):2147-2154 [PMID: 36472590]
  6. Am J Epidemiol. 2019 Aug 1;188(8):1466-1474 [PMID: 31197305]
  7. Pediatr Infect Dis J. 2017 Nov;36(11):1027-1031 [PMID: 28657970]
  8. Acta Otolaryngol. 2022 Mar-Apr;142(3-4):298-301 [PMID: 35404758]
  9. Int Arch Otorhinolaryngol. 2020 Apr;24(2):e175-e181 [PMID: 32256838]
  10. Emerg Infect Dis. 2019 Sep;25(9):1708-1718 [PMID: 31441745]
  11. Emerg Infect Dis. 2018 Jul;24(7):1275-1284 [PMID: 29912694]
  12. PLoS One. 2012;7(4):e36226 [PMID: 22558393]
  13. Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):575-583 [PMID: 27844262]
  14. Lancet. 2021 Sep 25;398(10306):1171-1183 [PMID: 34303412]
  15. Vaccine. 2012 Aug 31;30(40):5880-5 [PMID: 22771186]
  16. Crit Care. 2016 Oct 2;20(1):312 [PMID: 27716447]
  17. J Neurosci. 2016 Jul 20;36(29):7740-9 [PMID: 27445150]
  18. Lancet Infect Dis. 2021 Jan;21(1):137-147 [PMID: 32702302]
  19. Vaccine. 2018 Aug 28;36(36):5477-5484 [PMID: 28579230]
  20. J Laryngol Otol. 2010 Nov;124(11):1158-61 [PMID: 20441675]
  21. N Engl J Med. 2004 Oct 28;351(18):1849-59 [PMID: 15509818]
  22. Infection. 2007 Dec;35(6):406-13 [PMID: 18034205]
  23. Clin Microbiol Infect. 2020 Feb;26(2):199-204 [PMID: 31100424]
  24. N Engl J Med. 2009 Jan 15;360(3):244-56 [PMID: 19144940]
  25. BMC Infect Dis. 2005 Oct 27;5:93 [PMID: 16253143]
  26. Pediatr Infect Dis J. 2019 Aug;38(8):791-797 [PMID: 31220047]
  27. Vaccine. 2017 Oct 27;35(45):6160-6165 [PMID: 28951086]

MeSH Term

Humans
Sweden
Retrospective Studies
Adolescent
Male
Female
Child, Preschool
Adult
Child
Middle Aged
Otitis Media
Aged
Meningitis, Bacterial
Young Adult
Infant
Incidence
Risk Factors
Aged, 80 and over
Pneumococcal Vaccines
Streptococcus pneumoniae
Neisseria meningitidis

Chemicals

Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0meningitisAOMproportioncasesotogenicPCVincidencebacterialadultsBacterialotitismediastudyintroductionconjugatepneumococcalpatientssouthernSwedenannualidentifiedamongteenagerschildren < 2 yearspost-PCVincreasedBACKGROUND:rarelife-threateningdiseasesometimesoccurscomplicationacuteoriginatingclearPURPOSE:aiminvestigatecausedcompareriskfactorsbacteriologyoutcomenon-otogenicanalysevaccinesMETHODS:medicalchartsadmittedhospitals20002017retrievedBasedotoscopyand/orimagingcalculatedincidencesRESULTS:total21625died31%varied6%40%23%compared1%averageadultpopulationhandthoughlargevariationsSpneumoniaecommonlypathogeneveryoneNmeningitidispredominantCONCLUSION:importantcausechildrenThoughalmostdisappearedseemscommonmeningitis?retrospective18 yearsAcuteComplicationPneumococcalvaccine

Similar Articles

Cited By (2)